General Motors Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

General Motors Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,430	Closed	-$594K	–	711
2015 Q1	$594K	Sell	3,430 -4,505	-57%	-$815K	0.05%	408
2014 Q4	$1.47M	Hold	7,935	–	–	0.12%	148
2014 Q3	$1.32M	Sell	7,935 -3,189	-29%	-$524K	0.11%	175
2014 Q2	$1.74M	Buy	11,124 +898	+9%	+$142K	0.14%	114
2014 Q1	$1.56M	Buy	10,226 +5,926	+138%	+$942K	0.13%	124
2013 Q4	$572K	Sell	4,300 -9,608	-69%	-$1.15M	0.05%	440
2013 Q3	$1.62M	Buy	13,908 +10,192	+274%	+$1.12M	0.14%	132
2013 Q2	$343K	Buy	+3,716	New	+$358K	0.03%	537

Other funds holding ALXN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

General Motors Investment Management's ALXN Position: Q2 2015 in Review

General Motors Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q2 2015, closing a stake of 3,430 shares — an estimated $594K sold.

General Motors Investment Management first reported a position in ALXN in Q2 2013 and held it in 8 quarters. The position peaked at $1.74M in Q2 2014. 548 funds tracked by Wall St. Rank hold ALXN as of Q2 2015.

General Motors Investment Management reported no remaining Alexion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
General Motors Investment Management sold 3,430 Alexion Pharmaceuticals shares in Q2 2015, an estimated $594K.
General Motors Investment Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 8 quarters.
General Motors Investment Management's Alexion Pharmaceuticals position peaked at $1.74M in Q2 2014.
548 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2015.

Based on General Motors Investment Management's 13F filing for Q2 2015, filed 5 Aug 2015.